What is Rymedi?
Rymedi is dedicated to empowering the healthcare industry to foster collaboration and generate value across organizational silos. Leveraging technology engineered to meet the most stringent global regulatory standards, Rymedi facilitates the effective capture, tracking, and sharing of data among healthcare ecosystem participants. This capability enables smarter, accelerated health impact and enhances patient outcomes, positioning Rymedi as a critical player in health tech innovation.
How much funding has Rymedi raised?
Rymedi has raised a total of $9.2M across 2 funding rounds:
Debt
$150K
Series A
$9M
Debt (2020): $150K with participation from PPP
Series A (2023): $9M led by White Star Capital and Blockchange Ventures
Key Investors in Rymedi
White Star Capital
White Star Capital is a global multi-stage technology investment platform that partners with exceptional entrepreneurs to build ambitious international businesses. With a presence in major cities like New York, London, and Singapore, the firm focuses on venture investing at the Series A and B stages, as well as in digital assets and blockchain-enabled companies. Their team, equipped with extensive entrepreneurial and operational experience, supports founders in scaling their companies globally. White Star Capital aims to help reshape industries and drive innovation across transformative sectors.
Blockchange Ventures
We're a blockchain venture fund that backs extraordinary founders with visions as big and bold as the Blockchain itself. The company believes that the greatest business and investment outcomes from this generational technology shift will be the product of exceptional leadership and massive markets.
What's next for Rymedi?
The recent major strategic investment signals a significant growth phase for Rymedi, likely enabling further development and expansion of its regulatory-compliant data collaboration platform. This backing from prominent venture capital firms suggests a strong market validation and provides Rymedi with the resources to scale its operations, enhance its technological offerings, and solidify its position in the competitive health tech landscape. The company is poised to deepen its impact on improving patient care through advanced data solutions.
See full Rymedi company page
